1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia

BACKGROUND: Daptomycin-β-lactam (DAP-BL) combinations demonstrate in vitro synergy against MRSA; however, the clinical efficacy of combo is limited. Our objective was to compare the outcomes of patients with persistent MRSA bacteremia treated with DAP-BL combinations. METHODS: Retrospective, cohort...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Open Forum Infect Dis
Huvudupphovsmän: Bouchard, Jeannette, Oleksiuk, Louise-Marie, Shields, Ryan K
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2018
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254512/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.901
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk